Evidence map›Paper›PMID 31904361›Full record

ArticleExperimental eye research2020

In vitro response and gene expression of human retinal Müller cells treated with different anti-VEGF drugs.

Javier Cáceres-Del-Carpio, M Tarek Moustafa, Jaime Toledo-Corral, Mohamed A Hamid, Shari R Atilano, Kevin Schneider, Paula S Fukuhara, Rodrigo Donato Costa, J Lucas Norman, Deepika Malik and 5 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Experimental eye research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 2 countries.

Javier Cáceres-Del-CarpioGavin Herbert Eye Institute, University of California, Irvine, CA, USA.
M Tarek MoustafaGavin Herbert Eye Institute, University of California, Irvine, CA, USA.
Jaime Toledo-CorralGavin Herbert Eye Institute, University of California, Irvine, CA, USA.
Mohamed A HamidGavin Herbert Eye Institute, University of California, Irvine, CA, USA.
Shari R AtilanoGavin Herbert Eye Institute, University of California, Irvine, CA, USA.
Kevin SchneiderGavin Herbert Eye Institute, University of California, Irvine, CA, USA.
Paula S FukuharaGavin Herbert Eye Institute, University of California, Irvine, CA, USA.
Rodrigo Donato CostaGavin Herbert Eye Institute, University of California, Irvine, CA, USA.
J Lucas NormanGavin Herbert Eye Institute, University of California, Irvine, CA, USA.
Deepika MalikGavin Herbert Eye Institute, University of California, Irvine, CA, USA.
Marilyn ChwaGavin Herbert Eye Institute, University of California, Irvine, CA, USA.
David S BoyerRetina-Vitreous Associates Medical Group, Los Angeles, CA, USA.
G Astrid LimbDivision of Ocular Biology and Therapeutics, UCL Institute of Ophthalmology, London, UK.
M Cristina KenneyGavin Herbert Eye Institute, University of California, Irvine, CA, USA; Department of Pathology and Laboratory Medicine, University of California, Irvine, CA, USA. Electronic address: mkenney@hs.uci.edu.
Baruch D KuppermannGavin Herbert Eye Institute, University of California, Irvine, CA, USA; Department of Biomedical Engineering, University of California, Irvine, USA.
University of California, Irvine · USRetina Vitreous Associates Medical Group · USUniversity College London · GB

Funding

Protective Effects of Humanin on AMD MitochondriaR01EY027363 · NEI · UNIVERSITY OF CALIFORNIA-IRVINE · PI KENNEY, MARIA C · 2019 to 2021
$1.2M
Medical Research Council MR/P01660X/1NEI NIH HHS R01 EY027363
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

ActinsAngiogenesis InhibitorsAngiogenic ProteinsApoptosisApoptosis Regulatory ProteinsBevacizumabCarrier ProteinsCell LineCell SurvivalEpendymoglial CellsGene ExpressionGlial Fibrillary Acidic ProteinHumansInflammationMembrane Potential, MitochondrialOxidative Stress11-cis-retinal-binding proteinACTA2 protein, humanActinsafliberceptAngiogenesis InhibitorsAngiogenic ProteinsApoptosis Regulatory ProteinsBevacizumabCarrier ProteinsGFAP protein, humanGlial Fibrillary Acidic ProteinRanibizumabReactive Oxygen SpeciesReceptors, Vascular Endothelial Growth FactorRecombinant Fusion ProteinsVascular Endothelial Growth Factor AVEGFA protein, human

Identifiers

PMID31904361
PMCPMC7058176
OpenAlexW2997795125

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.